ARTICLE | Clinical News
PC-DAC:Exendin-4: Completed Phase II enrollment
September 15, 2008 7:00 AM UTC
ConjuChem Biotechnologies Inc. (TSX:CJB), Montreal, Quebec Product: PC-DAC:Exendin-4 ( CJC-1134-PC) Business: Endocrine Molecular target: Not applicable Description: Exendin-4 created through preform...